MY117590A - Orally administerable pharmaceutical formulations - Google Patents

Orally administerable pharmaceutical formulations

Info

Publication number
MY117590A
MY117590A MYPI9500500A MY117590A MY 117590 A MY117590 A MY 117590A MY PI9500500 A MYPI9500500 A MY PI9500500A MY 117590 A MY117590 A MY 117590A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical formulations
orally administerable
administerable pharmaceutical
orally
comrpising
Prior art date
Application number
Inventor
Lowell Lee Gibson
Kerry John Hartauer
Julian Larry Stowers
Stephanie Ann Sweetana
Arvind Lavji Thakkar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY117590A publication Critical patent/MY117590A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

THIS INVENTION PROVIDES ORALLY ADMINISTERABLE PHARMACEUTICAL FORMULATIONS COMRPISING RALOXIFENE, ITS ETHERS OR ESTERS, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF, IN COMBINATION WITH A HYDROPHILIC CARRIER COMPOSITION.
MYPI9500500 1994-03-02 1995-02-27 Orally administerable pharmaceutical formulations MY117590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20491594A 1994-03-02 1994-03-02

Publications (1)

Publication Number Publication Date
MY117590A true MY117590A (en) 2004-07-31

Family

ID=40909519

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9500500 MY117590A (en) 1994-03-02 1995-02-27 Orally administerable pharmaceutical formulations

Country Status (6)

Country Link
KR (1) KR100335580B1 (en)
CO (1) CO4340620A1 (en)
MY (1) MY117590A (en)
PE (1) PE8195A1 (en)
TW (1) TW327604B (en)
UA (1) UA39946C2 (en)

Also Published As

Publication number Publication date
KR100335580B1 (en) 2002-11-30
UA39946C2 (en) 2001-07-16
CO4340620A1 (en) 1996-07-30
TW327604B (en) 1998-03-01
PE8195A1 (en) 1995-04-14

Similar Documents

Publication Publication Date Title
HU9500635D0 (en) Orally administerable pharmaceutical formulations
PH31205A (en) Pharmaceutical composition.
GR3032366T3 (en) Pharmaceutical cyclosporin composition.
TNSN97009A1 (en) 2-OXO- AND 2-THIO- 1,2- DIHYDROQUINOLEINYL-OXAZOLIDINONES.
GR3018318T3 (en) Pharmaceutical agents.
ZA965190B (en) Pharmaceutical composition.
SE9704546D0 (en) Novel compounds
MX194243B (en) Oral composition.
TW200716550A (en) Pharmaceutical composition comprising ritonavir
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
OA09810A (en) Pharmaceutical composition.
ZA915932B (en) (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
EP0670166A3 (en) Formulations for orally administered pharmaceutical agents.
ZA92110B (en) Pharmaceutical compositions.
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
ZA918381B (en) Pharmaceutical compositions.
MY117590A (en) Orally administerable pharmaceutical formulations
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
ZA927369B (en) Pharmaceutical compositions.
AU9737198A (en) Pharmaceutical composition comprising 3,4-diarylchromans in low dose
ZA94434B (en) Pharmaceutical composition.
ZA92192B (en) Pharmaceutical compositions.
ZA917789B (en) Pharmaceutical preparation.
ZA957349B (en) Pharmaceutical formulations.
IT9021846A1 (en) PRETECTIVE ENVELOPE, PARTICULARLY DESIGNED FOR HOSPITAL USE.